Howrey LLP

About this office:

Howrey LLP is a world leader in intellectual property, antitrust/competition, and complex business litigation. Founded in 1956, Howrey LLP employs more than 550 attorneys, as well as over 50 economic, financial, environmental consultants, and economic research analysts in offices in Washington, D.C., Amsterdam, Brussels, Chicago, Houston, Irvine, London, Los Angeles, New York City, East Palo Alto, Salt Lake City, San Francisco and Taipei. Howrey is the second most-frequently mentioned firm in the National Law Journal's 2000 survey "Who Represents Corporate America," a listing of law firms preferred by Fortune 250 non-financial companies and ranked first in IP Worldwide's 1999 survey of "Who Represents the World's Most Valuable IP Rights?". Howrey is also the leading antitrust firm in the world according to the Global Competition Review (2003) and its attorneys include many former FTC and DOJ officials and current and former ABA officers, council members, and committee chairs. Unrivaled in our plaintiff and defense work in high-stakes cases, the firm has litigated in the federal courts of 49 states and represented clients in over 1,500 federal and state court cases since 1995 and handled 444 Supreme Court and appellate matters over the past 6 years. The firm is ranked in the top 25 firms nationally for its pro bono efforts.

General and Trial Practice including Antitrust, Commercial Litigation, Complex Tort, Corporate Responsibility, Corporate and Transactional, Environmental, Government Contracts, Insurance Coverage, Intellectual Property, International Trade, Products Liability, Securities Litigation, Supreme Court and Appellate and White Collar Criminal Defense.

USPTO Changes To Patent Rules Suspended
Michael J. Bell, April 22, 2008
As you may be aware, the U.S. Patent and Trademark Office instituted new patent rules which were to take effect November 1, 2007. We have just received word that implementation of these new rules was suspended due to the grant of a preliminary injunction in GlaxoSmithKline v. USPTO. Therefore, the...

Return to the Howrey LLP Firm Overview